Loading…
Based on limited metadata, this warning letter was issued to Amerigo Labs LLC on April 4, 2018, regarding an unspecified product category classified as "Other." Without access to the full letter text or detailed subject information, the specific nature of the violations cannot be determined from the available metadata. The issuing FDA office is also not identified in the records provided. To understand the regulatory concerns and required corrective actions, the complete warning letter would need to be reviewed.